Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Advanced ImmunoChemical, Inc.Supplier Diversity Partner Recombinant Human Insulin-Like Growth Factor Binding Protein 4, N-Terminal Fragment (NT-IGFBP-4), Source - Expressed in Human Cell LinePurity > 95% (Tricine-Sds-Page)  DFS Item

Manufacturer:  Advanced ImmunoChemical, Inc.Supplier Diversity Partner 8IGBPNRH0.05MG

This item is manufactured by HyTest, Ltd and distributed by Advanced ImmunoChemical, Inc. Antigens / Cardiac Markers / Recombinant human Insulin-like growth factor binding protein 4, N-terminal fragment (NT-IGFBP-4). Source:Expressed in human cell lineAnalysis:Purity > 95% (Tricine-SDS-PAGE).NT-IGFBP-4 concentration is determined spectrophotometrically.Immunoreactivity is confirmed by reaction with monoclonal antibodies specific to different epitopes of NT-IGFBP-4 molecule.Purification:Immunoaffinity purificationPresentation:Lyophilized from 20 mM Tris-HCl, 150 mM NaCl, pH 7.4Storage Conditions:Before and after reconstitution at -70 °C (between -65 and -80 °C allowed)Other information:Avoid repeated freezing and thawing.It is recommended to aliquot the product after the first thawing.Material safety note:This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

Catalog No. 50-153-9843

Add to cart

Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit